Breaking News, Collaborations & Alliances

Onyx to Manufacture API for Cancer Research UK

Will support a portfolio of drug substance campaigns

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Onyx Scientific has been selected by Cancer Research UK to manage several of its drug development projects. Onyx will support a portfolio of drug substance campaigns covering the development and manufacture of API, including process development, solid-state chemistry, analytical and GMP synthesis of API for use in Phase I trials.   Cancer Research UK initially selected Onyx for a GMP synthesis project in 2011. Onyx has since become one of its preferred providers for API development and GMP synth...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters